207 related articles for article (PubMed ID: 23041547)
1. Augmentation of therapeutic responses in melanoma by inhibition of IRAK-1,-4.
Srivastava R; Geng D; Liu Y; Zheng L; Li Z; Joseph MA; McKenna C; Bansal N; Ochoa A; Davila E
Cancer Res; 2012 Dec; 72(23):6209-16. PubMed ID: 23041547
[TBL] [Abstract][Full Text] [Related]
2. IRAK Inhibitor Protects the Intestinal Tract of Necrotizing Enterocolitis by Inhibiting the Toll-Like Receptor (TLR) Inflammatory Signaling Pathway in Rats.
Hou Y; Lu X; Zhang Y
Med Sci Monit; 2018 May; 24():3366-3373. PubMed ID: 29784900
[TBL] [Abstract][Full Text] [Related]
3. Toll-like receptor 2 dominance over Toll-like receptor 4 in stressful conditions for its detrimental role in the heart.
Bagchi AK; Akolkar G; Mandal S; Ayyappan P; Yang X; Singal PK
Am J Physiol Heart Circ Physiol; 2017 Jun; 312(6):H1238-H1247. PubMed ID: 28432060
[TBL] [Abstract][Full Text] [Related]
4. Induction of IRAK-M in melanoma induces caspase-3 dependent apoptosis by reducing TRAF6 and calpastatin levels.
Geng D; Ciavattone N; Lasola JJ; Shrestha R; Sanchez A; Guo J; Vlk A; Younis R; Wang L; Brown AJ; Zhang Y; Velasco-Gonzalez C; Tan AC; Davila E
Commun Biol; 2020 Jun; 3(1):306. PubMed ID: 32533049
[TBL] [Abstract][Full Text] [Related]
5. A central role for the Hsp90.Cdc37 molecular chaperone module in interleukin-1 receptor-associated-kinase-dependent signaling by toll-like receptors.
De Nardo D; Masendycz P; Ho S; Cross M; Fleetwood AJ; Reynolds EC; Hamilton JA; Scholz GM
J Biol Chem; 2005 Mar; 280(11):9813-22. PubMed ID: 15647277
[TBL] [Abstract][Full Text] [Related]
6. The kinase activities of interleukin-1 receptor associated kinase (IRAK)-1 and 4 are redundant in the control of inflammatory cytokine expression in human cells.
Song KW; Talamas FX; Suttmann RT; Olson PS; Barnett JW; Lee SW; Thompson KD; Jin S; Hekmat-Nejad M; Cai TZ; Manning AM; Hill RJ; Wong BR
Mol Immunol; 2009 Apr; 46(7):1458-66. PubMed ID: 19181383
[TBL] [Abstract][Full Text] [Related]
7. Regulation of IRAK-1 activation by its C-terminal domain.
Nguyen T; De Nardo D; Masendycz P; Hamilton JA; Scholz GM
Cell Signal; 2009 May; 21(5):719-26. PubMed ID: 19166926
[TBL] [Abstract][Full Text] [Related]
8. Down-regulation of IRAK-4 is a component of LPS- and CpG DNA-induced tolerance in macrophages.
De Nardo D; Nguyen T; Hamilton JA; Scholz GM
Cell Signal; 2009 Feb; 21(2):246-52. PubMed ID: 18992325
[TBL] [Abstract][Full Text] [Related]
9. IRAK-4 inhibitors for inflammation.
Wang Z; Wesche H; Stevens T; Walker N; Yeh WC
Curr Top Med Chem; 2009; 9(8):724-37. PubMed ID: 19689377
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-1 receptor associated kinases-1/4 inhibition protects against acute hypoxia/ischemia-induced neuronal injury in vivo and in vitro.
Yang YF; Chen Z; Hu SL; Hu J; Li B; Li JT; Wei LJ; Qian ZM; Lin JK; Feng H; Zhu G
Neuroscience; 2011 Nov; 196():25-34. PubMed ID: 21925238
[TBL] [Abstract][Full Text] [Related]
11. IRAK-2 participates in multiple toll-like receptor signaling pathways to NFkappaB via activation of TRAF6 ubiquitination.
Keating SE; Maloney GM; Moran EM; Bowie AG
J Biol Chem; 2007 Nov; 282(46):33435-33443. PubMed ID: 17878161
[TBL] [Abstract][Full Text] [Related]
12. TGF-β-induced IRAK-M expression in tumor-associated macrophages regulates lung tumor growth.
Standiford TJ; Kuick R; Bhan U; Chen J; Newstead M; Keshamouni VG
Oncogene; 2011 May; 30(21):2475-84. PubMed ID: 21278795
[TBL] [Abstract][Full Text] [Related]
13. 6-Bromoindirubin-3'-oxime inhibits JAK/STAT3 signaling and induces apoptosis of human melanoma cells.
Liu L; Nam S; Tian Y; Yang F; Wu J; Wang Y; Scuto A; Polychronopoulos P; Magiatis P; Skaltsounis L; Jove R
Cancer Res; 2011 Jun; 71(11):3972-9. PubMed ID: 21610112
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-1 receptor associated kinase inhibitors: potential therapeutic agents for inflammatory- and immune-related disorders.
Bahia MS; Kaur M; Silakari P; Silakari O
Cell Signal; 2015 Jun; 27(6):1039-55. PubMed ID: 25728511
[TBL] [Abstract][Full Text] [Related]
15. IRAK-1-mediated negative regulation of Toll-like receptor signaling through proteasome-dependent downregulation of TRAF6.
Muroi M; Tanamoto K
Biochim Biophys Acta; 2012 Feb; 1823(2):255-63. PubMed ID: 22033459
[TBL] [Abstract][Full Text] [Related]
16. IRAK-M is a negative regulator of Toll-like receptor signaling.
Kobayashi K; Hernandez LD; Galán JE; Janeway CA; Medzhitov R; Flavell RA
Cell; 2002 Jul; 110(2):191-202. PubMed ID: 12150927
[TBL] [Abstract][Full Text] [Related]
17. Effective Treatment of Metastatic Melanoma by Combining MAPK and PI3K Signaling Pathway Inhibitors.
Aasen SN; Parajuli H; Hoang T; Feng Z; Stokke K; Wang J; Roy K; Bjerkvig R; Knappskog S; Thorsen F
Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31470659
[TBL] [Abstract][Full Text] [Related]
18. Fisetin, a phytochemical, potentiates sorafenib-induced apoptosis and abrogates tumor growth in athymic nude mice implanted with BRAF-mutated melanoma cells.
Pal HC; Baxter RD; Hunt KM; Agarwal J; Elmets CA; Athar M; Afaq F
Oncotarget; 2015 Sep; 6(29):28296-311. PubMed ID: 26299806
[TBL] [Abstract][Full Text] [Related]
19. IRAK-4 kinase activity is required for interleukin-1 (IL-1) receptor- and toll-like receptor 7-mediated signaling and gene expression.
Koziczak-Holbro M; Joyce C; Glück A; Kinzel B; Müller M; Tschopp C; Mathison JC; Davis CN; Gram H
J Biol Chem; 2007 May; 282(18):13552-60. PubMed ID: 17337443
[TBL] [Abstract][Full Text] [Related]
20. Human interleukin-1 receptor-associated kinase-2 is essential for Toll-like receptor-mediated transcriptional and post-transcriptional regulation of tumor necrosis factor alpha.
Flannery SM; Keating SE; Szymak J; Bowie AG
J Biol Chem; 2011 Jul; 286(27):23688-97. PubMed ID: 21606490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
